2D-DIGE |
two-dimensional differential gel electrophoresis |
2-DE |
two-dimensional gel electrophoresis |
A1AG |
α-1-acid-glycoprotein |
A1BG |
α-1-B-glycoprotein |
ACE |
angiotensin-converting enzyme |
ADEM |
acute disseminated encephalomyelitis |
ALS |
amyotrophic lateral sclerosis |
ANO2 |
anoctamine-2 |
BBB |
blood–brain barrier |
BDNF |
brain-derived neurotrophic factor |
CCL11 |
Eotaxin-1 |
CCL20 |
chemokine ligand 20 |
CCN5 |
connective tissue growth factor/cysteine-rich protein/nephroblastoma overexpressed-5 |
CDMS |
clinically definitive multiple sclerosis |
CHI3L1 |
Chitinase-3-like protein 1 |
CHI3L2 |
Chitinase-3-like protein 2 |
CIDP |
chronic inflammatory demyelinating polyneuropathy |
CIS |
clinically isolated syndrome |
CNS |
central nervous system |
COX5b |
cytochrome C oxidase subunit 5b |
CSF |
cerebrospinal fluid |
DIS |
dissemination in space |
DIT |
dissemination in time |
DMF |
dimethyl-fumarate |
DMT |
disease modifying therapy |
EAE |
experimental autoimmune encephalomyelitis |
EAN |
European Academy of Neurology |
EBV |
Epstein–Barr virus |
ECTRIMS |
European Committee for Treatment and Research in Multiple Sclerosis |
EDSS |
expanded disability status scale |
ELISA |
enzyme-linked immunosorbent assay |
FNG |
fingolimod |
GA |
glatiramer-acetate |
Gd+ |
gadolinium |
GFAP |
glial fibrillary acidic protein |
GPI |
glucose-6-phosphate isomerase |
ICAT |
Isotope-coded affinity tag labeling |
IEC |
ion exchange chromatography |
IFN-β |
interferon-β |
IGF2 |
insulin-like growth factor 2 |
IGFBP7 |
insulin-like growth factor-binding protein 7 |
iTRAQ |
isobaric tag for relative and absolute quantitation |
LC-TMS |
liquid chromatography–tandem mass spectrometry |
LHON |
Leber’s Hereditary Optic Neuropathy |
MAPK |
mitogen-activated protein kinase |
MBP |
myelin basic protein |
MDR |
multidrug response |
MOG |
myelin oligodendrocyte glycoprotein |
MRI |
magnetic resonance imaging |
MS |
multiple sclerosis |
MSSS |
multiple sclerosis severity score |
NAT |
natalizumab |
NEDA |
no evidence of disease activity |
nFL |
neurofilament light chain |
NMOSD |
neuromyelitis optica spectrum disorder |
NMR spectroscopy |
nuclear magnetic resonance spectroscopy |
OGP |
oligoclonal gammopathy |
PEPB1 |
phosphatidylethanolamine-binding protein 1 |
PKCθ |
protein kinase C θ |
PKN |
prior knowledge signaling network |
PLP-1 |
proteolipid protein |
PPMS |
primary progressive multiple sclerosis |
PRDX6 |
peroxiredoxin 6 |
Prx1 |
peroxiredoxin-1 |
QoL |
quality of life |
RAAS |
renin–angiotensin–aldosterone system |
ROS |
reactive oxygen species |
RRMS |
relapsing-remitting multiple sclerosis |
RTN3 |
reticulon 3 |
SAP |
serum amyloid P component |
Scg1 |
secretogranin-1 |
SDS-PAGE |
sodium dodecyl sulfate-polyacrylamide gel electrophoresis |
SEC |
size exclusion chromatography |
SERPINA3 |
α-1-antichymotrypsin |
SILAC |
stable isotope labeling with amino acids in cell culture |
SIRTs |
silent information regulator proteins |
SLE |
systemic lupus erythematosus |
SPMS |
secondary progressive multiple sclerosis |
SST |
somatostatin |
STAT |
signal transducer and activator of transcription |
TAK1 |
TGF-β-activated kinase 1 |
TER |
teriflunomide |
TGF-β |
transforming growth factor beta |
TNF |
tumor necrosis factor |
VILIP-1 |
visinin-like protein |
vWF |
von Willebrand factor |